AbbVie Inc (ABBV) returns
AbbVie returns over 10 years
$1,000 invested in AbbVie ten years ago was worth $7,697 at the close on October 30, 2026, with dividends reinvested: an average return of 22.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +13.4% | — | $1,134 | -0.9% |
| 3 months | +15.3% | — | $1,153 | +2.1% |
| Year to date | +32.9% | — | $1,329 | +11.7% |
| 1 year | +33.1% | — | $1,331 | +12.4% |
| 3 years | +129.8% | +32.0% | $2,298 | +88.5% |
| 5 years | +207.4% | +25.2% | $3,074 | +76.0% |
| 10 years | +669.7% | +22.6% | $7,697 | +316.6% |
AbbVie return by calendar year
| Year | ABBV | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +32.9% | +11.7% | +21.2% |
| 2025 | +33.1% | +17.7% | +15.4% |
| 2024 | +18.9% | +24.9% | -6.0% |
| 2023 | -0.2% | +26.2% | -26.4% |
| 2022 | +24.0% | -18.2% | +42.2% |
| 2021 | +32.4% | +28.7% | +3.7% |
| 2020 | +27.6% | +18.4% | +9.2% |
| 2019 | +1.5% | +31.2% | -29.7% |
| 2018 | -1.0% | -4.6% | +3.6% |
| 2017 | +60.1% | +21.7% | +38.4% |
| 2016 | +9.9% | +12.0% | -2.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ABBV financials · ABBV valuation
No forecast, no recommendation. This page describes AbbVie Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.